BRCA2 and ovarian carcinoma: Analysis of the expanded 34 burden test genes revealed that patients with germline BRCA1 and BRCA2 truncations had significantly higher somatic mutation frequencies than cases without such changes in both breast and ovarian cancers (Fig. 5b and Supplementary Data 18).